Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Tangent screens help detect visual field defects from vigabatrin.

Skin reactions from cancer treatments might predict how well the treatments work.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Botanical extracts can improve scalp health by reducing oxidative stress.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

DCP in isopropanol is better tolerated for treating alopecia areata.

The substances improved hair regrowth and protected hair cells in humans and mice.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Liposomes and niosomes can help drugs penetrate the skin better.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Topical vitamin D is effective in treating vitiligo with few side effects.

Progesterone protects brain cells, but Provera does not.

TrichoSol™ and TrichoFoam™ are stable and effective for personalized alopecia treatments.

Topical tacrolimus is effective and safe for treating alopecia areata.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

New treatments using stem cells and special materials show promise for severe eye surface disease.

A homeopathic product reduces skin issues and stress in dogs with dermatitis.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.